Issue of Equity

27th Jan 2006 13:34

Akers Biosciences, Inc.27 January 2006 Akers Biosciences, Inc. (the "Company") Issue of Equity Akers Biosciences, Inc. today announces that on 25 January 2006, it approved theissue of 45,000 shares of common stock, no par value ("Common Shares") to DanielSeckinger, non-executive director, which represents 0.08% of the total sharecapital. The shares will be issued in lieu of unpaid directors' fees andexpenses in the amount of $58,423 (£34,650). The price per share for thistransaction was 72.75 pence. Dr. Seckinger has elected to have these shares allocated to several familymembers, so none of the shares resulting from this transaction will bebeneficially owned by him. Application has been made to the London Stock Exchange for the 45,000 CommonShares to be admitted to trading, such admission expected to take place on 31January 2006. Contact:Paul Freedman - 001 856 848 2116 END This information is provided by RNS The company news service from the London Stock Exchange

---

Related Shares:

AKR.L